Kilonzi, M.; Minzi, O.; Mutagonda, R.; Sasi, P.; Kamuhabwa, A.; Aklillu3, E.
(BMC, 2019)
Background: In 2006, artemether–lumefantrine (ALU), specifcally Coartem® (Novartis Pharma AG, Basel Switzerland),
was approved as the frst-line drug for treatment of uncomplicated malaria in Tanzania. Due to poor availability ...